We are live on ! Find out more
ILI

INTERLEUKIN GENETICS INC
ILI

Delisted

ILI was delisted on the 13th of August, 2010.

Back to rankings

1 hedge funds and large institutions have $119K invested in INTERLEUKIN GENETICS INC in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more capital invested

Capital invested by funds: $79K → $119K (+$40K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ILI Hedge Fund Activity: Q3 2016 in Review

1 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in INTERLEUKIN GENETICS INC (ILI) for Q3 2016, worth a combined $119K — up 51% from $79K a quarter earlier.

Fund positioning in ILI was balanced in Q3 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held INTERLEUKIN GENETICS INC (ILI) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $119K of INTERLEUKIN GENETICS INC stock for Q3 2016, up 51% quarter-over-quarter.
  • 0 funds opened new INTERLEUKIN GENETICS INC positions in Q3 2016 and 0 closed out.

Based on aggregated 13F filings for Q3 2016.